ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

Self Abrading Rapidly Applied Electrode Validation

ClinicalTrials.gov ID: NCT02200523

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02200523. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 4:39 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Self Abrading Rapidly Applied (SARA) Electrode Phase II

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The SARA (Self Abrading Rapidly Applied) electrode will speed EEG patient hookup by combining multiple steps that burden conventional EEG procedures into one. The investigators believe that the proposed system will reduce patient hookup time by more than 50% (from 40 to 20 minutes) with additional time savings on cleanup. Reducing the hookup time required for the EEG recording will make EEG more feasible in time critical situations and will improve patient care and service. The clinical testing in Phase II will investigate patient acceptance, clinician acceptance, time savings, and signal quality for 3 different environments: the large hospital institution, a small rural hospital setting and in an emergency department.

Study identification

NCT ID: NCT02200523
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Cleveland Medical Devices Inc; Industry
Enrollment: 40 participants

Conditions and interventions

Conditions

ELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)

Interventions

SARA electrode Device
Gold cup Device

Device

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 2014 (Type not available)
Primary completion: Aug 2015 (Actual)
Completion: Dec 2015 (Actual)
Last update posted: Aug 13, 2020

2014 – 2015

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
MetroHealth Research Institute	Cleveland	Ohio	44109	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02200523, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 13, 2020 · Synced Nov 14, 2026